Real World Evaluation of the Activity and Safety of Fostamatinib in Consecutive Adult Patients With ITP

Clinical trial NCT05613296 · COMPLETED

Trial details

NCT number: NCT05613296
Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto
Status: COMPLETED
Study type: OBSERVATIONAL

ITP - Immune Thrombocytopenia Chronic ITP Refractory ITP

Start date: 2023-05-05
Primary completion: 2024-05-31
Enrollment: 95

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.